Israel Englander Millennium Management
Israel “Izzy” Englander is the founder of Millennium Management, one of the world’s largest multi-strategy hedge fund platforms. Millennium allocates capital across hundreds of independent teams rather than a single house view, with rigorous risk controls at the platform level. Englander’s model has been highly influential in the rise of pod-shop multi-manager structures across the industry.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
DuPont de Nemours
DD
|
+$1.55B |
| 2 |
Comcast
CMCSA
|
+$449M |
| 3 |
SLB Ltd
SLB
|
+$298M |
| 4 |
Alphabet (Google) Class C
GOOG
|
+$281M |
| 5 |
Qualcomm
QCOM
|
+$228M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
ALXN
Alexion Pharmaceuticals
ALXN
|
+$229M |
| 2 |
Sempra
SRE
|
+$192M |
| 3 |
Bausch Health
BHC
|
+$183M |
| 4 |
BNY
Bank of New York Mellon
BNY
|
+$175M |
| 5 |
PepsiCo
PEP
|
+$173M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 12.58% |
| 2 | Energy | 11.62% |
| 3 | Consumer Discretionary | 8.89% |
| 4 | Financials | 8.63% |
| 5 | Technology | 8.43% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
3176
Titan Machinery
TITN
$444M
| $157K | ﹤0.01% |
13,654
-7,935
| -37% | -$108K |
|
|
GSOL
3177
DELISTED
Global Sources Ltd
GSOL
| $157K | ﹤0.01% |
18,896
-23,058
| -55% | -$182K |
|
3178
Crocs
CROX
$6.03B
| $154K | ﹤0.01% |
11,949
-19,392
| -62% | -$281K |
|
|
MSL
3179
DELISTED
Midsouth Bancorp, Inc.
MSL
| $154K | ﹤0.01% |
13,152
-1,997
| -13% | -$27.5K |
|
3180
Eledon Pharmaceuticals
ELDN
$277M
| $153K | ﹤0.01% |
+91
| New | +$187K |
|
|
PCOM
3181
DELISTED
Points.com Inc. Common Shares
PCOM
| $153K | ﹤0.01% |
14,065
-15,771
| -53% | -$165K |
|
|
REMY
3182
DELISTED
REMY INTL INC NEW COMMON
REMY
| $153K | ﹤0.01% |
5,230
-51,229
| -91% | -$1.46M |
|
3183
Milestone Scientific
MLSS
$42M
| $152K | ﹤0.01% |
+49,625
| New | +$152K |
|
3184
Nature's Sunshine
NATR
$252M
| $152K | ﹤0.01% |
+12,688
| New | +$158K |
|
|
EVOK
3185
DELISTED
Evoke Pharma
EVOK
| $150K | ﹤0.01% |
+357
| New | +$224K |
|
|
FRED
3186
DELISTED
Fred's Inc
FRED
| $150K | ﹤0.01% |
+12,700
| New | +$195K |
|
|
CTLP
3187
DELISTED
Cantaloupe
CTLP
| $149K | ﹤0.01% |
59,965
-830,570
| -93% | -$2.59M |
|
3188
VanEck Energy Income ETF
EINC
$79.6M
| $148K | ﹤0.01% |
+1,427
| New | +$184K |
|
|
LF
3189
DELISTED
LEAPFROG ENTERPRISES INC.
LF
| $148K | ﹤0.01% |
206,942
+58,568
| +39% | +$61.1K |
|
|
GLBR
3190
DELISTED
Global Brokerage, Inc. Class A Common Stock
GLBR
| $147K | ﹤0.01% |
16,862
-32,326
| -66% | -$334K |
|
|
AMFW
3191
DELISTED
AMEC Foster Wheeler plc
AMFW
| $147K | ﹤0.01% |
+13,521
| New | +$166K |
|
3192
Xcel Brands
XELB
$5.31M
| $146K | ﹤0.01% |
+1,700
| New | +$149K |
|
|
PGN
3193
DELISTED
PARAGON OFFSHORE PLC (GBR)
PGN
| $145K | ﹤0.01% |
603,800
-369,274
| -38% | -$251K |
|
|
SVA
3194
DELISTED
Sinovac Biotech, Ltd
SVA
| $145K | ﹤0.01% |
+28,500
| New | +$151K |
|
|
PRMW
3195
DELISTED
Primo Water Corporation
PRMW
| $145K | ﹤0.01% |
+19,257
| New | +$123K |
|
3196
DNP Select Income Fund
DNP
$4.13B
| $144K | ﹤0.01% |
+16,076
| New | +$159K |
|
3197
Arcturus Therapeutics
ARCT
$408M
| $142K | ﹤0.01% |
+3,354
| New | +$176K |
|
3198
KVH Industries
KVHI
$136M
| $141K | ﹤0.01% |
14,112
-28,255
| -67% | -$322K |
|
3199
Meritage Homes
MTH
$4.73B
| $141K | ﹤0.01% |
+7,736
| New | +$166K |
|
3200
Abeona Therapeutics
ABEO
$347M
| $139K | ﹤0.01% |
1,371
-349
| -20% | -$46.3K |
|
Similar funds
Israel Englander's Q3 2015 Portfolio in Review
As of Q3 2015, Israel Englander held 4,098 positions worth $51.6B, down 2.3% from $52.9B the previous quarter. Its ten largest holdings account for 14% of the portfolio.
Israel Englander deployed $5.12B of net new capital in Q3 2015, opening 839 new positions and adding to 1,320 existing holdings. Its largest new stake was BP: 4,551,492 shares worth $117M.
By sector, the portfolio is most concentrated in Healthcare at 13% of assets, down from 15% a quarter earlier, followed by Energy and Consumer Discretionary.
On the sell side, the largest reduction was Alexion Pharmaceuticals, an estimated $229M trimmed.
- Israel Englander's largest Q3 2015 buy was BP: 4,551,492 shares worth $117M.
- Israel Englander added most to DuPont de Nemours in Q3 2015, an estimated $1.55B increase.
- Israel Englander's biggest Q3 2015 reduction was Alexion Pharmaceuticals, cutting an estimated $229M.
- Israel Englander fully exited PepsiCo in Q3 2015, selling an estimated $173M.
- Israel Englander's ten largest holdings make up 14% of its $51.6B portfolio in Q3 2015.
- Israel Englander opened 839 new positions and closed 681 in Q3 2015.
- Israel Englander's portfolio value fell 2.3% quarter-over-quarter to $51.6B.
Based on Millennium Management's 13F filing for Q3 2015, filed 16 Nov 2015.